SpringWorks Therapeutics, Inc. (SWTX) Financials
Stock symbol SWTX is outdated, potentially delisted? Maybe it is available on other exchange?
SWTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2024 | 587.3 million | 106.2 million |
| Sept. 30, 2024 | 608.9 million | 76.3 million |
| June 30, 2024 | 617.3 million | 60.6 million |
| March 31, 2024 | 656.8 million | 89.4 million |
SWTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2024 | -35.6 million | 26.5 million |
| Sept. 30, 2024 | -16.0 million | 26.0 million |
| June 30, 2024 | -54.0 million | 26.2 million |
| March 31, 2024 | -79.5 million | 30.5 million |
SWTX Net Income
No data available :(
SWTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2024 | 308.0 million | 6.2 million | 7.9 million |
| Sept. 30, 2024 | 376.6 million | 5.7 million | 6.9 million |
| June 30, 2024 | 383.9 million | 6.1 million | 7.1 million |
| March 31, 2024 | 436.6 million | 5.6 million | 6.6 million |
SWTX Shares Outstanding
SWTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2024 | 6.1 million | 60.2 million | 77.1 million | - |
| Sept. 30, 2024 | 9.4 million | 42.3 million | 61.6 million | - |
| June 30, 2024 | 12.2 million | 44.4 million | 57.8 million | 844000 |
| March 31, 2024 | 577000 | 53.6 million | 59.4 million | -729000 |
SWTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2024 | 61.5 million | 5.6 million |
| Sept. 30, 2024 | 49.3 million | 3.3 million |
| June 30, 2024 | 59.7 million | 2.5 million |
| March 31, 2024 | 21.0 million | 1.9 million |
SWTX
Price: $46.99
52 week price:
Earnings Per Share: -3.41 USD
P/E Ratio: -13.78
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 625779
Market Capitalization: 3.5 billion